This article examines the difficulties in designing lyophilisation processes that can be faithfully scaled up to production volumes and suggests the most effective ways in which this can be achieved.
Maik Guttzeit
Advertisement
Maik Guttzeit is Head of Quality Assurance at GEA Pharma Systems, Germany.Tel: +49 2233 6999 401 maik.guttzeit@geagroup.com
Articles by Maik Guttzeit
Advertisement
Latest Updated Articles
Designing An Effective PAT-Driven Scale-Up Of Lyophilization ProcessesPublished: October 31st 2010 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
2
Standardizing Operations to Meet Global Sustainability and Resilience Goals
3
Dosage Form Innovations: A CPHI Frankfurt Conversation with Lonza’s Frank Romanski, Part One
4
Takeda’s Sriman Banerjee Discusses Smart Packaging at CPHI Frankfurt 2025
5
